I

ITF Therapeutics

Develops and commercializes rare-disease therapies

Senior Director, Neuromuscular Disorders - Medical Affairs

Biology & BiotechConfirmed live in the last 24 hours
Full-timeConcord, MA, USA$290k - $320kIn-person

About the Job

Requirements

  • An advanced degree is required: PharmD, MD, or PhD; PharmD is strongly preferred.
  • At least 10 years of progressive U.S. Medical Affairs experience in the pharmaceutical or biotechnology industry is required.
  • Prior leadership of cross-functional medical teams, including Medical Science Liaisons and medical communications, is required.
  • Deep knowledge of U.S. medical, regulatory, and pharmacovigilance standards is required.
  • Experience supporting an early marketed product is required.
  • Ability to build highly effective and accountable teams from the ground up is required.

Responsibilities

  • Lead development and execution of the U.S. medical strategy for givinostat in Duchenne muscular dystrophy.
  • Execute the U.S. Neurometabolic Medical Affairs strategy in alignment with corporate objectives and product lifecycle needs.
  • Implement and oversee U.S. medical plans for Duvyzat, integrating regulatory, clinical, commercial, and global medical perspectives.
  • Lead and develop the U.S. Neuromuscular Medical Affairs team, including Medical Science Liaisons.
  • Oversee medical education, scientific exchange, and non-registrational evidence-generation initiatives.
  • Act as a strategic thought partner across Medical Affairs, research and development, and commercial teams.
  • Provide medical and scientific support for late-stage clinical development programs, aligned with business and regulatory strategies.
  • Support training and development of internal teams on product science and disease education.
  • Implement systems and processes to optimize the effectiveness of the medical affairs neurometabolic organization.
  • Establish and maintain relationships with external medical experts, academic institutions, and medical societies.
  • Oversee a medical key opinion leader engagement and insights-generation strategy.
  • Localize medical information and publication resources.
  • Develop medical governance frameworks to maintain high ethical and compliance standards in all engagements.

Desired Qualifications

  • Experience in rare diseases, neurology, or neuromuscular disorders is strongly preferred.
  • PharmD is strongly preferred.

About the Company

ITF Therapeutics

Develops and commercializes rare-disease therapies

ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Concord, NH
Founded
2024

Recently Posted Jobs

Explore more opportunities at ITF Therapeutics

See more jobs